兴齐眼药：公司0.02%、0.04%硫酸阿托品滴眼液正在统筹市场推进计划，目前正处于生产备货阶段

Group 1 - The company has received drug registration approval for its 0.02% and 0.04% atropine eye drops from the National Medical Products Administration on January 4, 2026 [2] - The company is currently coordinating its market promotion plan and is in the production preparation stage [2]